Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) CohortCome Bommier,Mazie Tsang, Brie N. Noble,Carrie Thompson,Carla Casulo,Michelle Hildebrandt,Allison C. Rosenthal,Eric Mou,Urshila Durani,Annalynn M. Williams,Kathleen Yost,Melissa C. Larson,Brianna Gysbers,Matthew J. Maurer,Andrew L. Feldman,David L. Jaye,Peter Martin,Jonathon B. Cohen,Dai Chihara,Izidore S. Lossos,Christopher Strouse,Brad S. Kahl,Thomas M. Habermann,Christopher R. Flowers, Amylou Constance Dueck,James R. CerhanBLOOD（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
